| First Author | Coles GL | Year | 2020 |
| Journal | Cancer Cell | Volume | 38 |
| Issue | 1 | Pages | 129-143.e7 |
| PubMed ID | 32531271 | Mgi Jnum | J:293397 |
| Mgi Id | MGI:6448216 | Doi | 10.1016/j.ccell.2020.05.003 |
| Citation | Coles GL, et al. (2020) Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem Cells. Cancer Cell 38(1):129-143.e7 |
| abstractText | Using unbiased kinase profiling, we identified protein kinase A (PKA) as an active kinase in small cell lung cancer (SCLC). Inhibition of PKA activity genetically, or pharmacologically by activation of the PP2A phosphatase, suppresses SCLC expansion in culture and in vivo. Conversely, GNAS (G-protein alpha subunit), a PKA activator that is genetically activated in a small subset of human SCLC, promotes SCLC development. Phosphoproteomic analyses identified many PKA substrates and mechanisms of action. In particular, PKA activity is required for the propagation of SCLC stem cells in transplantation studies. Broad proteomic analysis of recalcitrant cancers has the potential to uncover targetable signaling networks, such as the GNAS/PKA/PP2A axis in SCLC. |
